阿迪波涅丁和代谢性心血管疾病:治疗机会和挑战
Xiaotian Lei1,2, Sheng Qiu1, Gangyi Yang1
1Endocrinology Department, The Second Affiliated Hospital of the Chongqing Medical University, Chongqing 400000, China.
Genes & diseases
|July 3, 2023
概括
低皮素水平与代谢性心血管疾病 (如心脏病发作和高血压) 有关. 了解阿迪波尼克丁的理解
科学领域:
- 心血管医学 心血管医学
- 代谢障碍 代谢障碍 代谢障碍
- 内分泌学 在内分泌学.
背景情况:
- 代谢性心血管疾病是全球主要的死亡原因,特别是在发展中国家.
- 这些疾病的危险因素通常与代谢障碍有关.
- 脂肪组织分泌阿迪波金,调节新陈代谢和疾病过程.
研究的目的:
- 分析阿迪波涅克丁与代谢性心血管疾病之间的复杂关系.
- 探索adiponectin的心脏保护和代谢调节作用.
- 确定心血管功能障碍的潜在治疗点.
主要方法:
- 文献综述和对有关阿迪波内克丁和心血管健康的现有研究的分析.
- 检查阿迪波内克水平与各种心血管疾病之间的相关性.
- 综合当前关于阿迪波内克的作用机制的理解.
主要成果:
- 阿迪波尼克丁是一种丰富的阿迪波金,具有胰岛素敏感性,抗动脉样硬化,抗炎和心脏保护作用.
- 低度的阿迪波涅丁与心肌梗塞,冠状动脉样硬化心脏病,高血压和高血压有显著的相关性.
- 根据阿迪波内克对心血管健康的影响的精确机制需要进一步阐明.
结论:
- 氨酸在代谢性心血管健康中起着至关重要的作用.
- 阿迪波内克丁缺乏症与几种心血管疾病的发病有关.
- 对阿迪波涅克机制的进一步研究可能会导致对代谢性心血管疾病的新型治疗策略.
更多相关视频
06:35Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
1.0K
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
9.9K
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Coronary Artery Disease I: Introduction
25
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25
Obesity
544
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
544
Glucagon-like Receptor Agonists
365
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
365
Regulation of the Cardiovascular System
1.2K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.2K
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
